|
1
|
Albertson DG: Gene amplification in
cancer. Trends Genet. 22:447–455. 2006.
|
|
2
|
Storlazzi CT, Lonoce A, Guastadisegni MC,
Trombetta D, D'Addabbo P, Daniele G, L'Abbate A, Macchia G, Surace
C, Kok K, et al: Gene amplification as double minutes or
homogeneously staining regions in solid tumors: Origin and
structure. Genome Res. 20:1198–1206. 2010.
|
|
3
|
Benner SE, Wahl GM and Von Hoff DD: Double
minute chromosomes and homogeneously staining regions in tumors
taken directly from patients versus in human tumor cell lines.
Anticancer Drugs. 2:11–25. 1991.
|
|
4
|
Turner KM, Deshpande V, Beyter D, Koga T,
Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson DA, et al:
Extrachromosomal oncogene amplification drives tumour evolution and
genetic heterogeneity. Nature. 543:122–125. 2017.
|
|
5
|
Menghi F, Barthel FP, Yadav V, Tang M, Ji
B, Tang Z, Carter GW, Ruan Y, Scully R, Verhaak RGW, et al: The
tandem duplicator phenotype is a prevalent genome-wide cancer
configuration driven by distinct gene mutations. Cancer Cell.
34:197–210.e5. 2018.
|
|
6
|
Gisselsson D, Jin Y, Lindgren D, Persson
J, Gisselsson L, Hanks S, Sehic D, Mengelbier LH, Øra I, Rahman N,
et al: Generation of trisomies in cancer cells by multipolar
mitosis and incomplete cytokinesis. Proc Natl Acad Sci USA.
107:20489–20493. 2010.
|
|
7
|
Korbel JO and Campbell PJ: Criteria for
inference of chromothripsis in cancer genomes. Cell. 152:1226–1236.
2013.
|
|
8
|
Meng X, Qi X, Guo H, Cai M, Li C, Zhu J,
Chen F, Guo H, Li J, Zhao Y, et al: Novel role for non-homologous
end joining in the formation of double minutes in
methotrexate-resistant colon cancer cells. J Med Genet. 52:135–144.
2015.
|
|
9
|
Cai M, Zhang H, Hou L, Gao W, Song Y, Cui
X, Li C, Guan R, Ma J, Wang X, et al: Inhibiting homologous
recombination decreases extrachromosomal amplification but has no
effect on intrachromosomal amplification in methotrexate-resistant
colon cancer cells. Int J Cancer. 144:1037–1048. 2019.
|
|
10
|
Hong Z, Jiang J, Hashiguchi K, Hoshi M,
Lan L and Yasui A: Recruitment of mismatch repair proteins to the
site of DNA damage in human cells. J Cell Sci. 121:3146–3154.
2008.
|
|
11
|
Surtees JA and Alani E: Mismatch repair
factor MSH2-MSH3 binds and alters the conformation of branched DNA
structures predicted to form during genetic recombination. J Mol
Biol. 360:523–536. 2006.
|
|
12
|
Lyndaker AM and Alani E: A tale of tails:
Insights into the coordination of 3' end processing during
homologous recombination. Bioessays. 31:315–321. 2009.
|
|
13
|
Takahashi M, Koi M, Balaguer F, Boland CR
and Goel A: MSH3 mediates sensitization of colorectal cancer cells
to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase
inhibitor. J Biol Chem. 286:12157–12165. 2011.
|
|
14
|
Dillon LW, Kumar P, Shibata Y, Wang YH,
Willcox S, Griffith JD, Pommier Y, Takeda S and Dutta A: Production
of extrachromosomal MicroDNAs is linked to mismatch repair pathways
and transcriptional activity. Cell Rep. 11:1749–1759. 2015.
|
|
15
|
Von Hoff DD, McGill JR, Forseth BJ,
Davidson KK, Bradley TP, Van Devanter DR and Wahl GM: Elimination
of extrachromosomally amplified MYC genes from human tumor cells
reduces their tumorigenicity. Proc Natl Acad Sci USA. 89:8165–8169.
1992.
|
|
16
|
Eckhardt SG, Dai A, Davidson KK, Forseth
BJ, Wahl GM and Von Hoff DD: Induction of differentiation in HL60
cells by the reduction of extrachromosomally amplified c-myc. Proc
Natl Acad Sci USA. 91:6674–6678. 1994.
|
|
17
|
Shimizu N, Shimura T and Tanaka T:
Selective elimination of acentric double minutes from cancer cells
through the extrusion of micronuclei. Mutat Res. 448:81–90.
2000.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
19
|
Pierce AJ, Hu P, Han M, Ellis N and Jasin
M: Ku DNA end- binding protein modulates homologous repair of
double-strand breaks in mammalian cells. Genes Dev. 15:3237–3242.
2001.
|
|
20
|
Bennardo N, Cheng A, Huang N and Stark JM:
Alternative-NHEJ is a mechanistically distinct pathway of mammalian
chromosome break repair. PLoS Genet. 4:e10001102008.
|
|
21
|
Morales C, García MJ, Ribas M, Miró R,
Muñoz M, Caldas C and Peinado MA: Dihydrofolate reductase
amplification and sensitization to methotrexate of
methotrexate-resistant colon cancer cells. Mol Cancer Ther.
8:424–432. 2009.
|
|
22
|
Chang DK, Ricciardiello L, Goel A, Chang
CL and Boland CR: Steady-state regulation of the human DNA mismatch
repair system. J Biol Chem. 275:18424–18431. 2000.
|
|
23
|
Syed A and Tainer JA: The MRE11-RAD50-NBS1
complex conducts the orchestration of damage signaling and outcomes
to stress in DNA replication and repair. Annu Rev Biochem.
87:263–294. 2018.
|
|
24
|
Startek M, Szafranski P, Gambin T,
Campbell IM, Hixson P, Shaw CA, Stankiewicz P and Gambin A:
Genome-wide analyses of LINE-LINE-mediated nonallelic homologous
recombination. Nucleic Acids Res. 43:2188–2198. 2015.
|
|
25
|
Simsek D and Jasin M: Alternative
end-joining is suppressed by the canonical NHEJ component
Xrcc4-ligase IV during chromosomal translocation formation. Nat
Struct Mol Biol. 17:410–416. 2010.
|
|
26
|
Sallmyr A and Tomkinson AE: Repair of DNA
double-strand breaks by mammalian alternative end-joining pathways.
J Biol Chem. 293:10536–10546. 2018.
|
|
27
|
Kisurina-Evgenieva OP, Sutiagina OI and
Onishchenko GE: Biogenesis of Micronuclei. Biochemistry (Mosc).
81:453–464. 2016.
|
|
28
|
Morales C, Ribas M, Aiza G and Peinado MA:
Genetic determinants of methotrexate responsiveness and resistance
in colon cancer cells. Oncogene. 24:6842–6847. 2005.
|
|
29
|
Zhang Y, Dong K, Jia X, Du S, Wang D, Wang
L, Qu H, Zhu S, Wang Y, Wang Z, et al: A novel extrachromosomal
circular DNA related genes signature for overall survival
prediction in patients with ovarian cancer. BMC Med Genomics.
16:1402023.
|
|
30
|
Hung KL, Yost KE, Xie L, Shi Q, Helmsauer
K, Luebeck J, Schöpflin R, Lange JT, Chamorro González R, Weiser
NE, et al: ecDNA hubs drive cooperative intermolecular oncogene
expression. Nature. 600:731–736. 2021.
|
|
31
|
Jiricny J: The multifaceted
mismatch-repair system. Nat Rev Mol Cell Biol. 7:335–346. 2006.
|
|
32
|
Jiricny J: Postreplicative mismatch
repair. Cold Spring Harb Perspect Biol. 5:a0126332013.
|
|
33
|
Chatterjee N, Lin Y and Wilson JH:
Mismatch repair enhances convergent transcription-induced cell
death at trinucleotide repeats by activating ATR. DNA Repair
(Amst). 42:26–32. 2016.
|
|
34
|
Bannister LA, Waldman BC and Waldman AS:
Modulation of error-prone double-strand break repair in mammalian
chromosomes by DNA mismatch repair protein Mlh1. DNA Repair (Amst).
3:465–474. 2004.
|
|
35
|
Zhu J, Yu Y, Meng X, Fan Y, Zhang Y, Zhou
C, Yue Z, Jin Y, Zhang C, Yu L, et al: De novo-generated small
palindromes are characteristic of amplicon boundary junction of
double minutes. Int J Cancer. 133:797–806. 2013.
|
|
36
|
Shammas MA, Shmookler Reis RJ, Koley H,
Batchu RB, Li C and Munshi NC: Dysfunctional homologous
recombination mediates genomic instability and progression in
myeloma. Blood. 113:2290–2297. 2009.
|
|
37
|
Marti TM, Kunz C and Fleck O: DNA mismatch
repair and mutation avoidance pathways. J Cell Physiol. 191:28–41.
2002.
|
|
38
|
Li GM: Mechanisms and functions of DNA
mismatch repair. Cell Res. 18:85–98. 2008.
|
|
39
|
Lieber MR: The mechanism of double-strand
DNA break repair by the nonhomologous DNA end-joining pathway. Annu
Rev Biochem. 79:181–211. 2010.
|
|
40
|
Smith JA, Waldman BC and Waldman AS: A
role for DNA mismatch repair protein Msh2 in error-prone
double-strand-break repair in mammalian chromosomes. Genetics.
170:355–363. 2005.
|
|
41
|
Shahi A, Lee JH, Kang Y, Lee SH, Hyun JW,
Chang IY, Jun JY and You HJ: Mismatch-repair protein MSH6 is
associated with Ku70 and regulates DNA double-strand break repair.
Nucleic Acids Res. 39:2130–2143. 2011.
|
|
42
|
Stavnezer J and Schrader CE: Mismatch
repair converts AID-instigated nicks to double-strand breaks for
antibody class-switch recombination. Trends Genet. 22:23–28.
2006.
|
|
43
|
Schrader CE, Guikema JE, Linehan EK,
Selsing E and Stavnezer J: Activation-induced cytidine
deaminase-dependent DNA breaks in class switch recombination occur
during G1 phase of the cell cycle and depend upon mismatch repair.
J Immunol. 179:6064–6071. 2007.
|
|
44
|
Eccleston J, Schrader CE, Yuan K,
Stavnezer J and Selsing E: Class switch recombination efficiency
and junction microhomology patterns in Msh2-, Mlh1-, and
Exo1-deficient mice depend on the presence of mu switch region
tandem repeats. J Immunol. 183:1222–1228. 2009.
|
|
45
|
Della-Maria J, Zhou Y, Tsai MS, Kuhnlein
J, Carney JP, Paull TT and Tomkinson AE: Human Mre11/human
Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act
together in an alternative nonhomologous end joining pathway. J
Biol Chem. 286:33845–33853. 2011.
|
|
46
|
Eccleston J, Yan C, Yuan K, Alt FW and
Selsing E: Mismatch repair proteins MSH2, MLH1, and EXO1 are
important for class-switch recombination events occurring in B
cells that lack nonhomologous end joining. J Immunol.
186:2336–2343. 2011.
|
|
47
|
Terradas M, Martín M and Genescà A:
Impaired nuclear functions in micronuclei results in genome
instability and chromothripsis. Arch Toxicol. 90:2657–2667.
2016.
|
|
48
|
Shimizu N, Kanda T and Wahl GM: Selective
capture of acentric fragments by micronuclei provides a rapid
method for purifying extrachromosomally amplified DNA. Nat Genet.
12:65–71. 1996.
|
|
49
|
Shimizu N, Itoh N, Utiyama H and Wahl GM:
Selective entrapment of extrachromosomally amplified DNA by nuclear
budding and micronucleation during S phase. J Cell Biol.
140:1307–1320. 1998.
|
|
50
|
Shimizu N, Misaka N and Utani K:
Nonselective DNA damage induced by a replication inhibitor results
in the selective elimination of extrachromosomal double minutes
from human cancer cells. Genes Chromosomes Cancer. 46:865–874.
2007.
|
|
51
|
Canute GW, Longo SL, Longo JA, Winfield
JA, Nevaldine BH and Hahn PJ: Hydroxyurea accelerates the loss of
epidermal growth factor receptor genes amplified as double-minute
chromosomes in human glioblastoma multiforme. Neurosurgery.
39:976–983. 1996.
|
|
52
|
Ambros IM, Rumpler S, Luegmayr A,
Hattinger CM, Strehl S, Kovar H, Gadner H and Ambros PF:
Neuroblastoma cells can actively eliminate supernumerary MYCN gene
copies by micronucleus formation-sign of tumour cell revertance?
Eur J Cancer. 33:2043–2049. 1997.
|
|
53
|
Prochazka P, Hrabeta J, Vícha A and
Eckschlager T: Expulsion of amplified MYCN from homogenously
staining chromosomal regions in neuroblastoma cell lines after
cultivation with cisplatin, doxorubicin, hydroxyurea, and
vincristine. Cancer Genet Cytogenet. 196:96–104. 2010.
|
|
54
|
Sawant A, Kothandapani A, Zhitkovich A,
Sobol RW and Patrick SM: Role of mismatch repair proteins in the
processing of cisplatin interstrand cross-links. DNA Repair (Amst).
35:126–136. 2015.
|
